ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Prometic strengthens its leadership with a new management structure and the appointment of three new directors
May 09, 2019Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or "Corporation") is pleased to announce today a new management structure to provide leadership to the Corporation and ... -
Prometic and Shenzen Royal Asset Management close transaction for JV and licensing rights to three p
August 23, 2017Deal provides Prometic with an initial $33 million, of which $23 million is receivable in H2 2017 -
Prometic and SRAM JV to develop and commercialise three drug candidates in China
April 01, 2017Prometic Life Sciences has signed a memorandum of terms with Shenzhen Royal Asset Management (SRAM) to establish a joint venture (JV) for the development, manufacture and commercialisation of three drug candidates, PBI-4050, PBI-4547 and PBI-4425, in Chin
Pharma Sources Insight January 2025
